Targeting m6A modifications of oncogenes such as EGFR and MYC can significantly suppress their expression and the proliferation of cancer cells [318]; demethylating metabolic gene PDK4 can reduce its expression and glycolysis of cancer cells [25]. Here, EGFR is linked to cancer.